1
|
Zou Y, Shan Z, Han Z, Yang J, Lin Y, Gong Z, Xie L, Xu J, Xie R, Chen Z, Chen Z. Regulating Blood Clot Fibrin Films to Manipulate Biomaterial-Mediated Foreign Body Responses. RESEARCH (WASHINGTON, D.C.) 2023; 6:0225. [PMID: 37719049 PMCID: PMC10503960 DOI: 10.34133/research.0225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Accepted: 08/20/2023] [Indexed: 09/19/2023]
Abstract
The clinical efficacy of implanted biomaterials is often compromised by host immune recognition and subsequent foreign body responses (FBRs). During the implantation, biomaterials inevitably come into direct contact with the blood, absorbing blood protein and forming blood clot. Many studies have been carried out to regulate protein adsorption, thus manipulating FBR. However, the role of clot surface fibrin films formed by clotting shrinkage in host reactions and FBR is often ignored. Because of the principle of fibrin film formation being relevant to fibrinogen or clotting factor absorption, it is feasible to manipulate the fibrin film formation via tuning the absorption of fibrinogen and clotting factor. As biological hydroxyapatite reserved bone architecture and microporous structure, the smaller particle size may expose more microporous structures and adsorb more fibrinogen or clotting factor. Therefore, we set up 3 sizes (small, <0.2 mm; medium, 1 to 2 mm; large, 3 to 4 mm) of biological hydroxyapatite (porcine bone-derived hydroxyapatite) with different microporous structures to investigate the absorption of blood protein, the formation of clot surface fibrin films, and the subsequent FBR. We found that small group adsorbed more clotting factors because of more microporous structures and formed the thinnest and sparsest fibrin films. These thinnest and sparsest fibrin films increased inflammation and profibrosis of macrophages through a potential signaling pathway of cell adhesion-cytoskeleton-autophagy, leading to the stronger FBR. Large group adsorbed lesser clotting factors, forming the thickest and densest fibrin films, easing inflammation and profibrosis of macrophages, and finally mitigating FBR. Thus, this study deepens the understanding of the role of fibrin films in host recognition and FBR and demonstrates the feasibility of a strategy to regulate FBR by modulating fibrin films via tuning the absorption of blood proteins.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Zetao Chen
- Hospital of Stomatology, Guanghua School of Stomatology,
Sun Yat-sen University and Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou 510055, China
| |
Collapse
|
2
|
Pliszczak-Król A, Kiełbowicz Z, Król J, Antończyk A, Gemra M, Skrzypczak P, Prządka P, Zalewski D, Bieżyński J, Nicpoń J. Parameters of Hemostasis in Sheep Implanted with Composite Scaffold Settled by Stimulated Mesenchymal Stem Cells-Evaluation of the Animal Model. MATERIALS 2021; 14:ma14226934. [PMID: 34832335 PMCID: PMC8622787 DOI: 10.3390/ma14226934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 11/07/2021] [Accepted: 11/12/2021] [Indexed: 11/26/2022]
Abstract
Implantation of composite scaffolds could be potentially associated with the risk of hemostatic disturbances in a recipient. However, there is a lack of information on possible alterations in clotting mechanisms resulting from such a procedure. The aim of the present work was to investigate changes in hemostatic parameters in sheep implanted with a scaffold composed of poly(ε-caprolactone) and hydroxyapatite and tricalcium phosphate (9:4.5:4.5), settled previously with mesenchymal stem cells stimulated by fibroblast growth factor-2 and bone morphogenetic protein-2. Nine Merino sheep were examined for 7 days, and measurements of clotting times (PT, aPTT), activities of antithrombin, protein C and clotting factors II-XII, and concentrations of fibrinogen and D-dimer were carried out before and 1 h, 24 h, 3 days and 7 days after scaffold implantation. The introduction of scaffold initially resulted in a slowdown of the clotting processes (most evident 24 h after surgery); PT and aPTT increased to 14.8 s and 33.9 s, respectively. From the third day onwards, most of these alterations began to return to normal values. The concentration of fibrinogen rose throughout the observation period (up to 8.4 g/L), mirroring the ongoing inflammatory reaction. However, no signals of significant disturbances in hemostatic processes were detected in the sheep tested.
Collapse
Affiliation(s)
- Aleksandra Pliszczak-Król
- Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland;
- Correspondence: ; Tel.: +48-6-6409-2994
| | - Zdzisław Kiełbowicz
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| | - Jarosław Król
- Department of Pathology, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland;
| | - Agnieszka Antończyk
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| | - Marianna Gemra
- Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland;
| | - Piotr Skrzypczak
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| | - Przemysław Prządka
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| | - Dariusz Zalewski
- Department of Genetics, Plant Breeding and Seed Production, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland;
| | - Janusz Bieżyński
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| | - Jakub Nicpoń
- Department and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland; (Z.K.); (A.A.); (P.S.); (P.P.); (J.B.); (J.N.)
| |
Collapse
|
3
|
Sevostianova VV, Antonova LV, Mironov AV, Yuzhalin AE, Silnikov VN, Glushkova TV, Godovikova TS, Krivkina EO, Bolbasov E, Akentyeva TN, Khanova MY, Matveeva VG, Velikanova EA, Tarasov RS, Barbarash LS. Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study. ACS OMEGA 2020; 5:21700-21711. [PMID: 32905385 PMCID: PMC7469394 DOI: 10.1021/acsomega.0c02593] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Accepted: 08/10/2020] [Indexed: 05/09/2023]
Abstract
Modification by Arg-Gly-Asp (RGD) peptides is a promising approach to improve the biocompatibility of biodegradable vascular patches for arteriotomy. In this study, we evaluated the performance of vascular patches electrospun using a blend of polycaprolactone (PCL) and polyhydroxybutyrate/valerate (PHBV) and additionally modified with RGDK, AhRGD, and c[RGDFK] peptides using 1,6-hexamethylenediamine or 4,7,10-trioxa-1,13-tridecanediamine (TTDDA) linkers. We examined mechanical properties and hemocompatibility of resulting patches before implanting them in rat abdominal aortas to assess their performance in vivo. Patches were explanted 1, 3, 6, and 12 months postoperation followed by histological and immunofluorescence analyses. Patches manufactured from the human internal mammary artery or commercially available KemPeriplas-Neo xenopericardial patches were used as a control. The tensile strength and F max of KemPeriplas-Neo patches were 4- and 16.7-times higher than those made of human internal mammary artery, respectively. Both RGD-modified and unmodified PHBV/PCL patches demonstrated properties similar to a human internal mammary artery patch. Regardless of RGD modification, experimental PHBV/PCL patches displayed fewer lysed red blood cells and resulted in milder platelet aggregation than KemPeriplas-Neo patches. Xenopericardial patches failed to form an endothelial layer in vivo and were prone to calcification. By contrast, TTDDA/RGDK-modified biodegradable patches demonstrated a resistance to calcification. Modification by TTDDA/RGDK and TTDDA/c[RGDFK] facilitated the formation of neovasculature upon the implantation in vivo.
Collapse
Affiliation(s)
- Viktoriia V. Sevostianova
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
- . Phone: +7-3842-643802
| | - Larisa V. Antonova
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Andrey V. Mironov
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Arseniy E. Yuzhalin
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Vladimir N. Silnikov
- Institute
of Chemical Biology and Fundamental Medicine of the Siberian Branch
of the Russian Academy of Sciences, Novosibirsk 630090, Russia
| | - Tatiana V. Glushkova
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Tatyana S. Godovikova
- Institute
of Chemical Biology and Fundamental Medicine of the Siberian Branch
of the Russian Academy of Sciences, Novosibirsk 630090, Russia
| | - Evgeniya O. Krivkina
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Evgeniy Bolbasov
- National
Research Tomsk Polytechnic University, Tomsk 634050, Russia
| | - Tatiana N. Akentyeva
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Mariam Yu. Khanova
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Vera G. Matveeva
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Elena A. Velikanova
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Roman S. Tarasov
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| | - Leonid S. Barbarash
- Research
Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
| |
Collapse
|
4
|
Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification. Polymers (Basel) 2019; 11:polym11010174. [PMID: 30960158 PMCID: PMC6401695 DOI: 10.3390/polym11010174] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2018] [Revised: 01/15/2019] [Accepted: 01/15/2019] [Indexed: 12/22/2022] Open
Abstract
Modification with Arg-Gly-Asp (RGD) peptides is a promising approach to improve biocompatibility of small-calibre vascular grafts but it is unknown how different RGD sequence composition impacts graft performance. Here we manufactured 1.5 mm poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(ε-caprolactone) grafts modified by distinct linear or cyclic RGD peptides immobilized by short or long amine linker arms. Modified vascular prostheses were tested in vitro to assess their mechanical properties, hemocompatibility, thrombogenicity and endothelialisation. We also implanted these grafts into rat abdominal aortas with the following histological examination at 1 and 3 months to evaluate their primary patency, cellular composition and detect possible calcification. Our results demonstrated that all modes of RGD modification reduce ultimate tensile strength of the grafts. Modification of prostheses does not cause haemolysis upon the contact with modified grafts, yet all the RGD-treated grafts display a tendency to promote platelet aggregation in comparison with unmodified counterparts. In vivo findings identify that cyclic Arg-Gly-Asp-Phe-Lys peptide in combination with trioxa-1,13-tridecanediamine linker group substantially improve graft biocompatibility. To conclude, here we for the first time compared synthetic small-diameter vascular prostheses with different modes of RGD modification. We suggest our graft modification regimen as enhancing graft performance and thus recommend it for future use in tissue engineering.
Collapse
|
5
|
Zarrintaj P, Manouchehri S, Ahmadi Z, Saeb MR, Urbanska AM, Kaplan DL, Mozafari M. Agarose-based biomaterials for tissue engineering. Carbohydr Polym 2018; 187:66-84. [PMID: 29486846 DOI: 10.1016/j.carbpol.2018.01.060] [Citation(s) in RCA: 323] [Impact Index Per Article: 53.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2017] [Revised: 12/28/2017] [Accepted: 01/18/2018] [Indexed: 01/08/2023]
Abstract
Agarose is a natural polysaccharide polymer having unique characteristics that give reason to consider it for tissue engineering applications. Special characteristics of agarose such as its excellent biocompatibility, thermo-reversible gelation behavior and physiochemical features support its use as a biomaterial for cell growth and/or controlled/localized drug delivery. The resemblance of this natural carbohydrate polymer to the extracellular matrix results in attractive features that bring about a strong interest in its usage in the field. The scope of this review is to summarize the extensive researches addressing agarose-based biomaterials in order to provide an in-depth understanding of its tissue engineering-related applications.
Collapse
Affiliation(s)
- Payam Zarrintaj
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | - Saeed Manouchehri
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | - Zahed Ahmadi
- Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
| | - Mohammad Reza Saeb
- Department of Resin and Additives, Institute for Color Science and Technology, P.O. Box: 16765-654, Tehran, Iran.
| | | | - David L Kaplan
- Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA
| | - Masoud Mozafari
- Bioengineering Research Group, Nanotechnology and Advanced Materials Department, Materials and Energy Research Center (MERC), Tehran, Iran; Cellular and Molecular Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran; Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
| |
Collapse
|
6
|
Flores-Arriaga JC, de Jesús Pozos-Guillén A, Escobar-García DM, Grandfils C, Cerda-Cristerna BI. Cell viability and hemocompatibility evaluation of a starch-based hydrogel loaded with hydroxyapatite or calcium carbonate for maxillofacial bone regeneration. Odontology 2017; 105:398-407. [PMID: 28386653 DOI: 10.1007/s10266-017-0301-x] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Accepted: 12/26/2016] [Indexed: 11/30/2022]
Abstract
The objective of this study is to evaluate the cell viability and hemocompatibility of starch-based hydrogels for maxillofacial bone regeneration. Seven starch-based hydrogels were prepared: three loaded with 0.5, 1 and 2% calcium carbonate (Sigma Aldrich, St. Louis, MO, USA); three loaded with 2, 3 and 4% hydroxyapatite (Sigma Aldrich); and one not loaded as a control. A 10 M NaOH was then added to induce hydrogel formation. Human osteoblasts were cultured on each hydrogel for 72 h. An MTS assay (Cell Titer96; PROMEGA, Madison, WI, USA) was used to assess cell viability. Hemocompatibility testing was conducted with normal human blood in the following conditions: 100 mg of each hydrogel in contact with 900 µL of whole blood for 15 min at 37 °C under lateral stirring. Higher percentages of cell viability were observed in starch-based hydrogels loaded with hydroxyapatite as compared with the control. The hemolysis test showed a hemolysis level lower than 2%. Activated partial thromboplastin time and prothrombin time were unchanged, while platelet counting showed a slight decrease when compared with controls.
Collapse
|
7
|
Tammaro L, Vittoria V, Calarco A, Petillo O, Riccitiello F, Peluso G. Effect of layered double hydroxide intercalated with fluoride ions on the physical, biological and release properties of a dental composite resin. J Dent 2013; 42:60-7. [PMID: 24239926 DOI: 10.1016/j.jdent.2013.10.019] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2013] [Revised: 10/30/2013] [Accepted: 10/31/2013] [Indexed: 01/09/2023] Open
Abstract
OBJECTIVES The aim of this work was the preparation of a new fluoride-releasing dental material characterized by a release of fluoride relatively constant over time without any initial toxic burst effect. This type of delivery is obtained by a matrix controlled elution and elicits the beneficial effect of a low amount of fluoride on human dental pulp stem cells (hDPSCs) towards mature phenotype. METHODS The modified hydrotalcite intercalated with fluoride ions (LDH-F), used as filler, was prepared via ion exchange procedure and characterized by X-ray diffraction and FT-IR spectroscopy. The LDH-F inorganic particles (0.7, 5, 10, 20wt.%) were mixed with a photo-activated Bis-GMA/TEGDMA (45/55wt/wt) matrix and novel visible-light cured composites were prepared. The dynamic thermo-mechanical properties were determined by dynamic mechanical analyzer. The release of fluoride ions in physiological solution was determined using a ionometer. Total DNA content was measured by a PicoGreen dsDNA quantification kit to assess the proliferation rate of hDPSCs. Alkaline phosphatase activity (ALP) was measured in presence of fluoride resins. RESULTS Incorporation of even small mass fractions (e.g. 0.7 and 5wt.%) of the fluoride LDH in Bis-GMA/TEGDMA dental resin significantly improved the mechanical properties of the pristine resin, in particular at 37°C. The observed reinforcement increases on increasing the filler concentration. The release of fluoride ions resulted very slow, lasting months. ALP activity gradually increased for 28 days in hDPSCs cell grown, demonstrating that low concentrations of fluoride contributed to the cell differentiation. CONCLUSIONS The prepared composites containing different amount of hydrotalcite filler showed improved mechanical properties, slow fluoride release and promoted hDPSCs cell proliferation and cell differentiation.
Collapse
Affiliation(s)
- Loredana Tammaro
- Department of Industrial Engineering, University of Salerno, Fisciano, SA, Italy.
| | - Vittoria Vittoria
- Department of Industrial Engineering, University of Salerno, Fisciano, SA, Italy
| | - Anna Calarco
- Institute of Protein Biochemistry, CNR, Naples, Italy; Institute of Biosciences and BioResources, CNR, Naples, Italy
| | - Orsolina Petillo
- Institute of Protein Biochemistry, CNR, Naples, Italy; Institute of Biosciences and BioResources, CNR, Naples, Italy
| | - Francesco Riccitiello
- Conservative Odontostomatology and Maxillofacial Surgery, University of Naples, Naples, Italy
| | - Gianfranco Peluso
- Institute of Protein Biochemistry, CNR, Naples, Italy; Institute of Biosciences and BioResources, CNR, Naples, Italy
| |
Collapse
|
8
|
Ruiz-Hitzky E, Darder M, Aranda P, Ariga K. Advances in biomimetic and nanostructured biohybrid materials. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2010; 22:323-36. [PMID: 20217713 DOI: 10.1002/adma.200901134] [Citation(s) in RCA: 194] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The rapid increase of interest in the field of biohybrid and biomimetic materials that exhibit improved structural and functional properties is attracting more and more researchers from life science, materials science, and nanoscience. Concomitant results offer valuable opportunities for applications that involve disciplines dealing with engineering, biotechnology, medicine and pharmacy, agriculture, nanotechnology, and others. In the current contribution we collect recent illustrative examples of assemblies between materials of biological origin and inorganic solids of different characteristics (texture, structure, and particle size). We introduce here a general overview on strategies for the preparation and conformation of biohybrids, the synergistic effects that determine the final properties of these materials, and their diverse applications, which cover areas as different as tissue engineering, drug delivery systems, biosensing devices, biocatalysis, green nanocomposites, etc.
Collapse
|
9
|
Matsusaki M, Kadowaki K, Tateishi K, Higuchi C, Ando W, Hart DA, Tanaka Y, Take Y, Akashi M, Yoshikawa H, Nakamura N. Scaffold-Free Tissue-Engineered Construct–Hydroxyapatite Composites Generated by an Alternate Soaking Process: Potential for Repair of Bone Defects. Tissue Eng Part A 2009; 15:55-63. [DOI: 10.1089/ten.tea.2007.0424] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Michiya Matsusaki
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
- 21st Century COE Program “Center for Integrated Cell and Tissue Regulation,” Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
| | - Koji Kadowaki
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
| | - Kosuke Tateishi
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Chikahisa Higuchi
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Wataru Ando
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - David A. Hart
- Faculty of Medicine, McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, Canada
| | - Yoshinari Tanaka
- 21st Century COE Program “Center for Integrated Cell and Tissue Regulation,” Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Yasuhiro Take
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Mitsuru Akashi
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
- 21st Century COE Program “Center for Integrated Cell and Tissue Regulation,” Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
| | - Hideki Yoshikawa
- 21st Century COE Program “Center for Integrated Cell and Tissue Regulation,” Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Norimasa Nakamura
- 21st Century COE Program “Center for Integrated Cell and Tissue Regulation,” Graduate School of Engineering, Osaka University, Suita, Osaka, Japan
- Department of Orthopaedics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| |
Collapse
|